PRKRIR expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.54021240206248E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.00364161426114E-13 |
Normal-vs-Stage2 |
1.724900E-03 |
Normal-vs-Stage3 |
3.50550000000061E-05 |
Normal-vs-Stage4 |
9.41559999967367E-07 |
Stage1-vs-Stage2 |
2.603000E-01 |
Stage1-vs-Stage3 |
2.277800E-01 |
Stage1-vs-Stage4 |
8.603000E-01 |
Stage2-vs-Stage3 |
9.417600E-01 |
Stage2-vs-Stage4 |
5.209000E-01 |
Stage3-vs-Stage4 |
5.743600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.3875346144564E-12 |
Normal-vs-AfricanAmerican |
8.34519997550132E-09 |
Normal-vs-Asian |
8.11270000000697E-05 |
Caucasian-vs-AfricanAmerican |
4.126000E-01 |
Caucasian-vs-Asian |
9.294600E-01 |
AfricanAmerican-vs-Asian |
5.840400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.7874590696465E-14 |
Normal-vs-Female |
5.788900E-04 |
Male-vs-Female |
7.75800000000215E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.59780000008602E-07 |
Normal-vs-Extreme_Weight |
1.64734892393881E-12 |
Normal-vs-Obese |
5.17620000195507E-08 |
Normal-vs-Extreme_Obese |
5.92000000132487E-08 |
Normal_Weight-vs-Extreme_Weight |
1.049570E-01 |
Normal_Weight-vs-Obese |
8.223000E-01 |
Normal_Weight-vs-Extreme_Obese |
1.841020E-01 |
Extreme_Weight-vs-Obese |
4.480300E-02 |
Extreme_Weight-vs-Extreme_Obese |
5.430000E-01 |
Obese-vs-Extreme_Obese |
1.560040E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.436760E-01 |
Normal-vs-Age(41-60Yrs) |
1.34499966719659E-10 |
Normal-vs-Age(61-80Yrs) |
1.69975145070111E-12 |
Normal-vs-Age(81-100Yrs) |
1.94560034749713E-10 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.516000E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.861300E-03 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.435300E-03 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.951800E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.480400E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.707600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
4.81836792687318E-14 |
Normal-VS-Type2 PRCC |
5.44642109190363E-12 |
Normal-VS-KIRP CIMP |
5.935600E-01 |
Normal-VS-Unclassified PRCC |
4.39469999999886E-05 |
Type1 PRCC-VS-Type2 PRCC |
8.908200E-01 |
Type1 PRCC-VS-KIRP CIMP |
4.822100E-03 |
Type1 PRCC-VS-Unclassified PRCC |
3.405000E-01 |
Type2 PRCC-VS-KIRP CIMP |
3.5088000000072E-05 |
Type2 PRCC-VS-Unclassified PRCC |
3.739200E-01 |
KIRP CIMP-VS-Unclassified PRCC |
5.962500E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
9.99200722162641E-16 |
Normal-vs-N1 |
3.202400E-02 |
Normal-vs-N2 |
1.59371999999269E-05 |
N0-vs-N1 |
3.878700E-03 |
N0-vs-N2 |
4.299600E-01 |
N1-vs-N2 |
9.112300E-02 |
|
|